Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include very common findings: Ataxia; and common findings: Mild intellectual disability, Dystonia, Seizure, and Macrocephaly and others. 39 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Mild intellectual disability, Dystonia, Seizure |
NAA60 encodes N-alpha-acetyltransferase 60, NatF catalytic subunit (242 aa). N-alpha-acetyltransferase that specifically mediates the acetylation of N-terminal residues of the transmembrane proteins, with a strong preference for N-termini facing the cytosol. Highest expression in Brain Cerebellum (45.9 TPM) and Brain Cerebellar Hemisphere (42.7 TPM).
Basal ganglia calcification, idiopathic, 9, autosomal recessive is associated with mutations in the NAA60 gene on chromosome 16.
NAA60 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for NAA60 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for basal ganglia calcification, idiopathic, 9, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 11 common features.
No clinical trials have been registered for basal ganglia calcification, idiopathic, 9, autosomal recessive.
5 publications have been identified in PubMed for basal ganglia calcification, idiopathic, 9, autosomal recessive. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Monfrini E (2025). [PMID: 41059649](https://pubmed.ncbi.nlm.nih.gov/41059649/). *Mov Disord*. [Basic Science / Preclinical]
Yektay Farahmand M (2025). [PMID: 40947452](https://pubmed.ncbi.nlm.nih.gov/40947452/). *J Neurol*. [Review / Meta-Analysis]
Yang D (2025). [PMID: 40456615](https://pubmed.ncbi.nlm.nih.gov/40456615/). *eNeuro*. [Review / Meta-Analysis]
Emmi A (2025). [PMID: 39935191](https://pubmed.ncbi.nlm.nih.gov/39935191/). *Ann Clin Transl Neurol*. [Diagnostic / Biomarker]
Bonato G (2024). [PMID: 38999439](https://pubmed.ncbi.nlm.nih.gov/38999439/). *J Clin Med*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 9:45 PM UTC
Online Mendelian Inheritance in Man
Common questions about basal ganglia calcification, idiopathic, 9, autosomal recessive
3 |
High palate, Macrocephaly, Microcephaly |
Eyes | 2 | Strabismus, Developmental cataract |
Arms and legs | 1 | Proximal upper limb amyotrophy |
Growth and development | 1 | Short stature |
Muscles | 1 | Low muscle tone (hypotonia) |
Digestive system | 1 | Difficulty swallowing (dysphagia) |